West Lafayette, IN, United States of America

Xufeng Cao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xufeng Cao. Retrieved from https://idiyas.com/inventor/xufeng-cao-28furk6m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xufeng Cao: Innovator in Antibiotic Development

Introduction

Xufeng Cao is a notable inventor based in West Lafayette, Indiana, recognized for his contributions to the field of antibiotic development. His work primarily focuses on addressing the challenges posed by multidrug-resistant bacteria, which have become a significant concern in modern medicine.

Latest Patents

Cao holds a patent for "Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria." This invention relates to novel therapeutic compounds, specifically carbonic anhydrase inhibitors that serve as narrow-spectrum antibiotics. These compounds are designed to combat drug-resistant bacterial infections in mammals, providing a promising avenue for treatment.

Career Highlights

Cao is affiliated with the Purdue Research Foundation, where he continues to advance his research and innovation in antibiotic therapies. His work is crucial in the ongoing battle against antibiotic resistance, a growing public health threat.

Collaborations

Cao collaborates with esteemed colleagues, including Daniel Patrick Flaherty and Mohamed Seleem, who contribute to his research efforts and enhance the impact of his inventions.

Conclusion

Xufeng Cao's innovative work in developing carbonic anhydrase inhibitors represents a significant advancement in the fight against multidrug-resistant bacteria. His contributions are vital for improving therapeutic options and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…